Differential determinants and prognostic value of aortic valve sclerosis over carotid atherosclerosis

Minjeong Kim1, Jiwon Seo2, In-Soo Kim2

  • 1Division of Cardiology, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.

PubMed

Insights

Aortic valve sclerosis (AVS) predicts cardiovascular events and heart failure. However, AVS is a surrogate marker for vascular atherosclerosis and left ventricular dysfunction, not an independent risk factor.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Atherosclerosis Research

Background:

  • Aortic valve sclerosis (AVS) is a progressive atherosclerotic disease linked to cardiovascular events (CVE).
  • The independence of AVS development and prognostic value from arterial atherosclerosis requires investigation.
  • This study evaluates AVS determinants and prognostic value alongside carotid atherosclerosis.

Purpose of the Study:

  • To determine the factors influencing aortic valve sclerosis (AVS) development.
  • To assess the prognostic significance of AVS for future cardiovascular events (CVE) and heart failure (HF).
  • To investigate the relationship between AVS, carotid atherosclerosis, and cardiovascular outcomes.

Main Methods:

  • 4688 patients underwent carotid ultrasonography and echocardiography.
  • Exclusion criteria included bicuspid aortic valve, rheumatic heart disease, overt aortic stenosis, and prior aortic valve replacement.
  • AVS was defined as thickened, hyper-echogenic aortic valve cusps with a peak pressure gradient <2.5 m/s.

Main Results:

  • 11% of patients had AVS, independently correlated with age, diabetes, low HDL, and carotid plaques.
  • AVS was associated with atherosclerotic CVE (acute coronary syndromes, all-cause death) and future heart failure (HF) admissions.
  • AVS predicted atherosclerotic CVE independently of age and sex, but this association was attenuated by carotid plaques. HF admissions were linked to LV systolic and diastolic dysfunction.

Conclusions:

  • Aortic valve sclerosis (AVS) is a prognostic marker for future cardiovascular events (CVE) and heart failure (HF).
  • Atherosclerotic CVE risk is primarily mediated by vascular atherosclerosis.
  • Future HF admissions are mainly driven by left ventricular (LV) systolic and diastolic dysfunction, indicating AVS is a surrogate marker.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...